Lantern Pharma LTRN
NASDAQ LTRN
$0.64 -0.03 (-4.05%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Cash & Current Investments (2019 - 2026)

Updated

Lantern Pharma's Cash & Current Investments was $7.36 million in Q2 2026, down 53.7% from $15.9 million a year earlier but up 16.4% from the prior quarter.

Analysis

Lantern Pharma (LTRN) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Lantern Pharma came in at $10.12 million, down 57.9% from FY2024.

  • Cash & Current Investments has now declined for four consecutive years, with a five-year compound annual growth rate of -12.0% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $24.01 million in FY2024 (-41.9%), $41.3 million in FY2023 (-25.2%), $55.2 million in FY2022 (-22.0%) and $70.73 million in FY2021 (+267.8%).
  • Quarterly Cash & Current Investments has moved between $6.32 million (Q1 2026) and $73.83 million (Q3 2021) over five years.
  • Compared with a year earlier, Cash & Current Investments has declined for 18 straight quarters, with an average decline of 52.0% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2021 (growth of 267.8%); the worst was Q1 2026 (a decline of 67.9%).
  • Per Business Quant data, LTRN's Cash & Current Investments in the three quarters before Q2 2026 was $6.32 million (Q1 2026), $10.12 million (Q4 2025) and $12.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 20.76 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 6.57 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 4.90 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 3.18 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 11.70 Bn
10 Lantern Pharma 7.95 Mn -28.21 Mn - 7.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.36 Mn
Mar 31, 2026 6.32 Mn
Dec 31, 2025 10.12 Mn
Sep 30, 2025 12.36 Mn
Jun 30, 2025 15.90 Mn
Mar 31, 2025 19.72 Mn
Dec 31, 2024 24.01 Mn
Sep 30, 2024 28.05 Mn
Jun 30, 2024 33.26 Mn
Mar 31, 2024 38.36 Mn
Dec 31, 2023 41.30 Mn
Sep 30, 2023 44.93 Mn
Jun 30, 2023 47.95 Mn
Mar 31, 2023 51.54 Mn
Dec 31, 2022 55.20 Mn
Sep 30, 2022 57.83 Mn
Jun 30, 2022 62.15 Mn
Mar 31, 2022 65.22 Mn
Dec 31, 2021 70.73 Mn
Sep 30, 2021 73.83 Mn
API Access

Lantern Pharma Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LTRN&period=max&api_key=YOUR_API_KEY